Invalid Symbol

Stock Research for ACUS

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


ACUS Stock Chart & Research Data

The ACUS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACUS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ACUS Due diligence Resources & Stock Charts

The ACUS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ACUS Detailed Price Forecast - CNN Money CNN View ACUS Detailed Summary - Google Finance
Yahoo View ACUS Detailed Summary - Yahoo! Finance Zacks View ACUS Stock Research & Analysis -

Stock Analysis

TradeIdeas View ACUS Trends & Analysis - Trade-Ideas Barrons View ACUS Major Holders - Barrons
NASDAQ View ACUS Call Transcripts - NASDAQ Seeking View ACUS Breaking News & Analysis - Seeking Alpha
Spotlight View ACUS Annual Report - OTC Report View ACUS OTC Short Report -
TradeKing View ACUS Fundamentals - TradeKing Charts View ACUS SEC Filings - Bar Chart
WSJ View Historical Prices for ACUS - The WSJ Morningstar View Performance/Total Return for ACUS - Morningstar
MarketWatch View the Analyst Estimates for ACUS - MarketWatch CNBC View the Earnings History for ACUS - CNBC
StockMarketWatch View the ACUS Earnings - StockMarketWatch MacroAxis View ACUS Buy or Sell Recommendations - MacroAxis
Bullish View the ACUS Bullish Patterns - American Bulls Short Pains View ACUS Short Pain Metrics -

Social Media Mentions

StockTwits View ACUS Stock Mentions - StockTwits PennyStocks View ACUS Stock Mentions - PennyStockTweets
Twitter View ACUS Stock Mentions - Twitter Invest Hub View ACUS Investment Forum News - Investor Hub
Yahoo View ACUS Stock Mentions - Yahoo! Message Board Seeking Alpha View ACUS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ACUS - Insider Cow View Insider Transactions for ACUS - Insider Cow
CNBC View ACUS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ACUS - OTC Markets
Yahoo View Insider Transactions for ACUS - Yahoo! Finance NASDAQ View Institutional Holdings for ACUS - NASDAQ

Stock Charts

FinViz View ACUS Stock Insight & Charts - StockCharts View ACUS Investment Charts -
BarChart View ACUS Stock Overview & Charts - BarChart Trading View View ACUS User Generated Charts - Trading View

Latest Financial News for ACUS

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Acusphere Withdraws its European Marketing Authorization Application for Imagify
Business Wire (press release) - Aug 28, 2014
Acusphere, Inc. (ACUSD.PK) is a specialty pharmaceutical company focused on the development and regulatory approval of our lead product candidate, Imagify™ (Perflubutane Polymer Microspheres for Injectable Suspension).

Acusphere Fights Celgene's Bid For Atty Fees In Patent Row
Law360 - Aug 19, 2015
Law360, New York (August 19, 2015, 12:20 PM EDT) -- Specialty pharmaceutical company Acusphere Inc. fought back Tuesday against Celgene Corp.

Technical Views: Tracking Shares of Acusphere Inc (ACUS)
The Business Union - Jan 13, 2018
Traders might be taking a second look at shares of Acusphere Inc (ACUS). After a recent spotcheck, we can see that the SuperTrend line is now above the current stock price.

IRX Therapeutics' Board of Directors Announces New Senior Management ...
Business Wire (press release) - Mar 16, 2017
Mr. Leuchtenberger was President and Chief Executive Officer and a member of the board of directors at Chiasma (NASDAQ: CHMA), Acusphere, Inc. (OTCMKTS: ACUS) and Rib-X Pharmaceuticals, Inc. (now Melinta Therapeutics, Inc.). Mr. Leuchtenberger served ...

Enter a stock symbol to view the stock details.